ArticleBMC veterinary research2026
Multifocal non-epitheliotrophic cutaneous B-cell Lymphoma in a dog: cytologic, histopathologic, immunophenotypic, and molecular findings.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCutaneous B-cell lymphoma is extremely rare in dogs; only few cases have been reported in veterinary literature, and its clinicopathological characteristics, biological behavior, and classification remain incompletely characterized. CASE PRESENTATION: A 12-year-old spayed female Shih Tzu presented with extensive, multifocal subcutaneous nodules. Histopathology revealed infiltration of neoplastic lymphoid cells within the dermis and subcutaneous tissue without epidermal involvement. Immunohistochemistry revealed strong positivity for cluster of differentiation (CD)79a and paired box 5 (PAX5), no CD3 expression, strong nuclear expression of multiple myeloma oncogene 1 (MUM-1), and a relatively low Ki-67 labeling index (14.28%), suggesting limited proliferative activity. Flow cytometric analysis confirmed B cell dominance, and polymerase chain reaction for antigen receptor rearrangement (PARR) demonstrated clonal rearrangement of the immunoglobulin heavy chain gene. Cytological evaluation of the liver and spleen did not reveal definitive evidence of lymphoma infiltration, and PARR analysis of the splenic aspirate showed polyclonal lymphoid population, providing no molecular evidence of clonal lymphoid proliferation. Despite treatment with cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP)-based chemotherapy, only a transient partial response was observed, followed by rapid disease progression.
conclusionThis case report describes a rare multifocal non-epitheliotrophic cutaneous B-cell lymphoma in a dog, characterized by aggressive biological behavior, high proliferative activity, and poor response to conventional chemotherapy. These findings highlight the need for further studies to better define the clinicopathological spectrum and optimal management of canine cutaneous B-cell lymphoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.